News Zhuhai Rundu Pharmaceutical Co., Ltd.

Stocks

002923

CNE1000033G8

Pharmaceuticals

End-of-day quote Shenzhen S.E. 29/10/2026			5-day change	1st Jan Change
8.920 ^CNY	-1.65%		-3.04%	-26.58%

08-20	Zhuhai Rundu Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
05-22	Zhuhai Rundu Pharmaceutical Wins China Approval for Pain Relief Drug	MT

All News

Mentions Relevance

08-20	Zhuhai Rundu Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
05-22	Zhuhai Rundu Pharmaceutical Wins China Approval for Pain Relief Drug	MT
05-19	China Grants Zhuhai Rundu Pharmaceutical Marketing Approval for Hypertension Drug	MT
05-07	Zhuhai Rundu says key shareholder plans to unload up to 3% stake	RE
05-06	Zhuhai Rundu Pharmaceutical's shareholder plans to unload shares	RE
05-06	Rundu Pharmaceutical Gets Nod to Market Losartan Potassium	MT
04-27	Zhuhai Rundu Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-07	Zhuhai Rundu Pharmaceutical Gets China Approval for Cardiac Stress Testing Drug	MT
03-06	Zhuhai Rundu Pharmaceutical Co., Ltd. Approves Election of Hu Zhengxi as Independent Director	CI
02-25	Rundu Pharmaceutical Gets Registration Certificate for Ibuprofen Tablets	MT
02-13	China Selects 12 Zhuhai Rundu Pharmaceutical Products for National Procurement Program	MT
01-21	Rundu Pharmaceutical Gets Nod for Marketing of Sacubitril/Valsartan Sodium	MT
12-14	Zhuhai Rundu Pharmaceutical's shareholders plan to cut stakes	RE
31/10/25	Zhuhai Rundu Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025	CI
17/10/25	Rundu Pharmaceutical Gets China Marketing Nod for Chest Pain Tablets	MT
26/09/25	Zhuhai Rundu Pharmaceutical Gets China Supplementary Nod for Herpes Drug	MT
29/08/25	Zhuhai Rundu Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025	CI
13/08/25	Zhuhai Rundu Pharmaceutical Gets Marketing Approval for Osteoarthritis API	MT
05/08/25	Zhuhai Rundu Pharmaceutical Gets Approval for Muscle Relaxant	MT
20/07/25	Rundu Pharma's shareholder to unload up to 3% stake in co	RE
04/07/25	Rundu Pharmaceutical Gets Registration Certificate for Moxifloxacin Hydrochloride Tablets	MT
30/06/25	Zhuhai Rundu Pharmaceutical Passes Brazilian GMP Certification for Four APIs	MT
27/06/25	Zhuhai Rundu Pharmaceutical Passes US FDA On-Site Manufacturing Practice Inspection	MT
21/05/25	Zhuhai Rundu Pharmaceutical Co., Ltd. Approves Final Cash Dividend on A Shares for 2024, Payable on 30 May 2025	CI
14/05/25	Rundu Pharmaceutical Gets Regulatory Approval for Veterinary Antibiotic	MT